MedPath

MULTIPLE MYELOMA RESEARCH FOUNDATION

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1998-01-01
Employees
-
Market Cap
-
Website
http://www.themmrf.org/

Clinical Trials

3

Active:1
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

MMRF CureCloud Research Initiative

Terminated
Conditions
Multiple Myeloma
First Posted Date
2018-09-05
Last Posted Date
2024-01-05
Lead Sponsor
Multiple Myeloma Research Foundation
Target Recruit Count
1105
Registration Number
NCT03657251
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Multiple Myeloma Research Foundation, Norwalk, Connecticut, United States

๐Ÿ‡บ๐Ÿ‡ธ

Washington University Medical Campus, Saint Louis, Missouri, United States

๐Ÿ‡บ๐Ÿ‡ธ

Hackensack University Medical Center, Hackensack, New Jersey, United States

and more 1 locations

MMRF Molecular Profiling Protocol

Active, not recruiting
Conditions
Plasma Malignancy
Multiple Myeloma
First Posted Date
2016-08-30
Last Posted Date
2025-05-06
Lead Sponsor
Multiple Myeloma Research Foundation
Target Recruit Count
1000
Registration Number
NCT02884102
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic - Scottsdale, Scottsdale, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

City of Hope, Duarte, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

UCSF Medical Center, San Francisco, California, United States

and more 17 locations

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

Completed
Conditions
Multiple Myeloma
First Posted Date
2011-10-19
Last Posted Date
2024-01-03
Lead Sponsor
Multiple Myeloma Research Foundation
Target Recruit Count
1154
Registration Number
NCT01454297
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic Campus in Scottsdale, AZ, Scottsdale, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

UC San Diego Moores Cancer Center, San Diego, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Sharp Health Care, San Diego, California, United States

and more 70 locations

News

MMRF's Horizon Trial Program Enrolls First Patient to Optimize Myeloma Treatment

The Multiple Myeloma Research Foundation (MMRF) has initiated its Horizon Clinical Trials Program, enrolling the first patient in a study of relapsed and refractory myeloma.

ยฉ Copyright 2025. All Rights Reserved by MedPath